The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy

Cancers - Switzerland
doi 10.3390/cancers11121894
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Kinetics, Prognostic and Predictive Values of ESR1 Circulating Mutations in Metastatic Breast Cancer Patients Progressing on Aromatase Inhibitor

Oncotarget
Oncology
2016English

Pharmacogenetics and Breast Cancer Endocrine Therapy: CYP2D6 as a Predictive Factor for Tamoxifen Metabolism and Drug Response?

Expert Reviews in Molecular Medicine
Molecular MedicineMolecular Biology
2008English

Predicting Response/Resistance to Endocrine Therapy for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Dedicator of Cytokinesis 4: A Potential Prognostic and Predictive Biomarker Within the Metastatic Spread of Breast Cancer to Bone

Cancer Informatics
Cancer ResearchOncology
2019English

Endocrine Therapy of Breast Cancer

2008English

Prognostic and Predictive Role of Tumour-Associated Macrophages in HER2 Positive Breast Cancer

Scientific Reports
Multidisciplinary
2019English

Neoadjuvant Endocrine Therapy in Breast Cancer: Current Role and Future Perspectives

ecancermedicalscience
Cancer ResearchOncology
2016English

How to Improve Endocrine Therapy of Breast Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1990English

Hormone Receptor-Negative as a Predictive Factor for Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer

Einstein (São Paulo, Brazil)
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy